ArticleBritish journal of sports medicine2026
Dual-energy X-ray absorptiometry per cent fat Z-score as a predictor of menstrual status in adolescent and young adult female athletes.
Article in British journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWeight/fat mass gain to support resumption of normal menses can be an important treatment goal for female athletes with amenorrhoea (AMEN) or oligomenorrhoea (OLIGO) related to relative energy deficiency in sport (REDs). However, targets based on body mass index (BMI) or per cent expected body weight (%EBW) may be less applicable in athletes, who typically have greater lean mass compared with the general population. Our aim was to determine if dual-energy X-ray absorptiometry (DXA)-derived %fat Z-score can detect menstrual status in female athletes and if a %fat Z-score cut-off of <-1.0 is a better indicator than standard BMI (in those >20 years) or %EBW (in those ≤20 years) thresholds.
methods388 female athletes (age 15-30 years, Tier ≥2) with DXA scans were classified as AMEN (n=159), OLIGO (n=84) or naturally menstruating (NM, n=145) using clinical records. We compared %fat Z-score and BMI or %EBW values across menstrual groups and calculated sensitivity and specificity for predicting AMEN and the combined OLIGO and AMEN groups (OLIGO/AMEN) using traditional BMI or %EBW risk cut-offs versus a risk cut-off of <-1.0 for %fat Z-score.
results%fat Z-score was superior to traditional BMI or %EBW thresholds in discriminating between menstrual status groups. Using a %fat Z-score cut-off <-1.0 improved sensitivity (p<0.0001) for predicting AMEN (68.9%) and OLIGO/AMEN (57.7%) compared with the sensitivity of traditional BMI or %EBW cut-offs for AMEN (29.3%) and OLIGO/AMEN (25.9%). However, %fat Z-score <-1.0 did not improve specificity for predicting AMEN (75.4%) nor OLIGO/AMEN (79.9%) compared with the specificity of traditional BMI or %EBW cut-offs for AMEN (83.9%; p=0.0078) and OLIGO/AMEN (85.2%; p=0.14).
conclusionsWhen attempting to resume normal menstruation, achieving a %fat Z-score ≥-1.0, rather than using BMI or %EBW targets, may be a better goal for athletes with REDs-related amenorrhoea or oligomenorrhoea.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.